Dentsply Sirona (XRAY) Falls 2% Following In-Line Q1, Lower Outlook

Late Sunday, Dentsply Sirona (NASDAQ: XRAY) reported Q1 EPS of $0.45, in-line with the analyst estimate of $0.45. Revenue for the quarter came in at $956.1 million versus the consensus estimate of $940.8 million.

Dentsply Sirona also said sees FY2018 EPS of $2.55-$2.65, versus the consensus of $2.70.

The Board of Directors authorizes an increase of $500 Million in share repurchase program, bringing total current authorization to $1 billion.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49